Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antiparasitic drugs >  Anthelmintics >  Diaveridine

Diaveridine

Basic information Safety Supplier Related

Diaveridine Basic information

Product Name:
Diaveridine
Synonyms:
  • DIAVERIDIN
  • DIAVERIDINE
  • 5-[(3,4-DIMETHOXYPHENYL)METHYL]-2,4-PYRIMIDINEDIAMINE
  • 5-(3,4-DIMETHOXYBENZYL)-2,4-PYRIMIDINEDIAMINE
  • 5-(3,4-DIMETHOXY-BENZYL)-PYRIMIDINE-2,4-DIAMINE
  • 2,4-DIAMINO-5-(3,4-DIMETHOXY BENZYL)PYRIMIDINE
  • 2,4-Diamino-5-veratrylpyrimidine
  • 5-(3,4-Dimethoxybenzyl)-2,4-diaminopyrimidine
CAS:
5355-16-8
MF:
C13H16N4O2
MW:
260.29
EINECS:
226-333-3
Mol File:
5355-16-8.mol
More
Less

Diaveridine Chemical Properties

Melting point:
233°
Boiling point:
506.1±60.0 °C(Predicted)
Density 
1.252±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,2-8°C
solubility 
DMSO (Slightly)
pka
7.11±0.10(Predicted)
form 
Solid
color 
White to Pale Yellow
Merck 
13,3017
BRN 
258464
InChI
InChI=1S/C13H16N4O2/c1-18-10-4-3-8(6-11(10)19-2)5-9-7-16-13(15)17-12(9)14/h3-4,6-7H,5H2,1-2H3,(H4,14,15,16,17)
InChIKey
LDBTVAXGKYIFHO-UHFFFAOYSA-N
SMILES
C1(N)=NC=C(CC2=CC=C(OC)C(OC)=C2)C(N)=N1
CAS DataBase Reference
5355-16-8(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36
WGK Germany 
2
RTECS 
UV8142000
HS Code 
29335990

MSDS

More
Less

Diaveridine Usage And Synthesis

Uses

Antibacterial.

Uses

Diaveridine is a dihydrofolate reductase inhibitor. It is used in veterinary medicine as a drug for its anticoccidial properties and its function as an antibacterial synergist.

Definition

ChEBI: An aminopyrimidine in which the pyrimidine ring carries amino substituents at C-2 and C-4 and a 3,4-dimethoxybenzyl group at C-5. A folic acid antagonist, it is used as a synergist with sulfonamides against the parasitic Eimeria species.

in vivo

The sperm abnormality of the Diaveridine (DVD) treatment groups at all dose levels (Diaveridine, 128 to 512 mg/kg) shows no significant differences compare with the negative control group. There are no significant differences of micronucleus between the negative control group and the Diaveridine treatment groups (Diaveridine, 128 to 512 mg/kg). The chromosome aberration of the Diaveridine treatment groups at all dose levels and the negative control group are significantly lower than those in the positive control group treated with cyclophosphamide (P<0.05), indicating that Diaveridine at the doses studied does not cause abnormal chromosome aberration. The results demonstrate that the Diaveridine administration does not produce significant changes in the ratio of organ-to-body weight, compare with the negative control group in the end period of the study[3].

Diaveridine Preparation Products And Raw materials

Raw materials

DiaveridineSupplier

Hubei Zhonglong Kangsheng Fine Chemical Co., Ltd. Gold
Tel
027-83855385 13407122916
Email
13037171113@163.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
XiaoGan ShenYuan ChemPharm co,ltd
Tel
15527768836
Email
1791901229@qq.com
Sinopharm Chemical Reagent Co,Ltd.
Tel
86-21-63210123
Email
sj_scrc@sinopharm.com
Hangzhou Yuhao Chemical Technology Co., Ltd
Tel
0571-82693216
Email
info@yuhaochemical.com